JPMorgan Chase & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6M | Sell |
647,372
-569,774
| -47% | -$31.3M | ﹤0.01% | 1387 |
|
|
2025
Q1 | $86M | Sell |
1,217,146
-328,510
| -21% | -$23.2M | 0.01% | 917 |
|
|
2024
Q4 | $102M | Sell |
1,545,656
-1,266,133
| -45% | -$83.2M | 0.01% | 839 |
|
|
2024
Q3 | $198M | Buy |
2,811,789
+218,608
| +8% | +$15.4M | 0.02% | 650 |
|
|
2024
Q2 | $213M | Buy |
2,593,181
+171,179
| +7% | +$14.1M | 0.02% | 597 |
|
|
2024
Q1 | $212M | Sell |
2,422,002
-25,790
| -1% | -$2.25M | 0.02% | 597 |
|
|
2023
Q4 | $236M | Sell |
2,447,792
-171,040
| -7% | -$16.5M | 0.02% | 532 |
|
|
2023
Q3 | $232M | Buy |
2,618,832
+7,515
| +0.3% | +$665K | 0.03% | 482 |
|
|
2023
Q2 | $226M | Buy |
2,611,317
+57,391
| +2% | +$4.97M | 0.02% | 501 |
|
|
2023
Q1 | $248M | Sell |
2,553,926
-6,718
| -0.3% | -$653K | 0.03% | 447 |
|
|
2022
Q4 | $265M | Buy |
2,560,644
+506,252
| +25% | +$52.4M | 0.03% | 402 |
|
|
2022
Q3 | $174M | Buy |
2,054,392
+439,075
| +27% | +$37.2M | 0.03% | 496 |
|
|
2022
Q2 | $134M | Buy |
1,615,317
+24,508
| +2% | +$2.03M | 0.02% | 602 |
|
|
2022
Q1 | $123M | Buy |
1,590,809
+296,868
| +23% | +$22.9M | 0.01% | 714 |
|
|
2021
Q4 | $114M | Sell |
1,293,941
-1,635,035
| -56% | -$144M | 0.01% | 761 |
|
|
2021
Q3 | $226M | Sell |
2,928,976
-826,403
| -22% | -$63.9M | 0.03% | 505 |
|
|
2021
Q2 | $313M | Buy |
3,755,379
+919,767
| +32% | +$76.7M | 0.04% | 445 |
|
|
2021
Q1 | $214M | Buy |
2,835,612
+353,531
| +14% | +$26.7M | 0.03% | 517 |
|
|
2020
Q4 | $218M | Sell |
2,482,081
-737,788
| -23% | -$64.7M | 0.03% | 471 |
|
|
2020
Q3 | $245M | Buy |
3,219,869
+429,959
| +15% | +$32.7M | 0.04% | 392 |
|
|
2020
Q2 | $344M | Buy |
2,789,910
+174,900
| +7% | +$21.6M | 0.07% | 273 |
|
|
2020
Q1 | $221M | Buy |
2,615,010
+773,068
| +42% | +$65.3M | 0.05% | 321 |
|
|
2019
Q4 | $156M | Buy |
1,841,942
+1,301,029
| +241% | +$110M | 0.03% | 475 |
|
|
2019
Q3 | $36.5M | Sell |
540,913
-206,645
| -28% | -$13.9M | 0.01% | 1008 |
|
|
2019
Q2 | $62.8M | Sell |
747,558
-102,872
| -12% | -$8.64M | 0.01% | 785 |
|
|
2019
Q1 | $75.5M | Sell |
850,430
-310,002
| -27% | -$27.5M | 0.02% | 699 |
|
|
2018
Q4 | $98.8M | Sell |
1,160,432
-247,433
| -18% | -$21.1M | 0.02% | 574 |
|
|
2018
Q3 | $137M | Buy |
1,407,865
+201,425
| +17% | +$19.5M | 0.03% | 533 |
|
|
2018
Q2 | $114M | Buy |
1,206,440
+151,058
| +14% | +$14.2M | 0.02% | 562 |
|
|
2018
Q1 | $85.6M | Sell |
1,055,382
-527,403
| -33% | -$42.8M | 0.02% | 657 |
|
|
2017
Q4 | $141M | Buy |
1,582,785
+102,061
| +7% | +$9.1M | 0.03% | 479 |
|
|
2017
Q3 | $138M | Sell |
1,480,724
-179,395
| -11% | -$16.7M | 0.03% | 491 |
|
|
2017
Q2 | $151M | Sell |
1,660,119
-547,061
| -25% | -$49.7M | 0.03% | 450 |
|
|
2017
Q1 | $194M | Sell |
2,207,180
-1,030,288
| -32% | -$90.4M | 0.04% | 384 |
|
|
2016
Q4 | $268M | Sell |
3,237,468
-463,593
| -13% | -$38.4M | 0.06% | 283 |
|
|
2016
Q3 | $343M | Buy |
3,701,061
+325,518
| +10% | +$30.1M | 0.08% | 237 |
|
|
2016
Q2 | $263M | Sell |
3,375,543
-1,110,895
| -25% | -$86.4M | 0.07% | 293 |
|
|
2016
Q1 | $370M | Sell |
4,486,438
-1,144,155
| -20% | -$94.4M | 0.09% | 228 |
|
|
2015
Q4 | $590M | Buy |
5,630,593
+472,390
| +9% | +$49.5M | 0.15% | 156 |
|
|
2015
Q3 | $543M | Buy |
5,158,203
+2,438,282
| +90% | +$257M | 0.15% | 158 |
|
|
2015
Q2 | $372M | Buy |
2,719,921
+1,174,260
| +76% | +$161M | 0.09% | 247 |
|
|
2015
Q1 | $193M | Buy |
1,545,661
+991,462
| +179% | +$124M | 0.04% | 414 |
|
|
2014
Q4 | $50.1M | Buy |
554,199
+62,328
| +13% | +$5.63M | 0.01% | 850 |
|
|
2014
Q3 | $35.5M | Sell |
491,871
-366,348
| -43% | -$26.4M | 0.01% | 981 |
|
|
2014
Q2 | $53.4M | Sell |
858,219
-65,828
| -7% | -$4.1M | 0.01% | 809 |
|
|
2014
Q1 | $63M | Buy |
924,047
+592,150
| +178% | +$40.4M | 0.02% | 685 |
|
|
2013
Q4 | $23.3M | Sell |
331,897
-66,925
| -17% | -$4.71M | 0.01% | 1160 |
|
|
2013
Q3 | $28.8M | Sell |
398,822
-418,202
| -51% | -$30.2M | 0.01% | 1050 |
|
|
2013
Q2 | $45.5M | Buy |
+817,024
| New | +$45.5M | 0.01% | 743 |
|